118 related articles for article (PubMed ID: 32518840)
1. Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
Gupta P; Prieto-Merino D; Ajay VS; Singh K; Roy A; Krishnan A; Narayan KMV; Ali MK; Tandon N; Prabhakaran D; Perel P
Wellcome Open Res; 2019; 4():71. PubMed ID: 32518840
[No Abstract] [Full Text] [Related]
2. Recalibration of the Framingham risk score for predicting 10-year risk of cardiovascular events: A non-concurrent rural cohort study from Tamil Nadu.
Sasikumar M; Oommen AM; Mohan VR; Gupta P; Rebekah G; Abraham VJ; George K
Indian Heart J; 2023; 75(1):47-52. PubMed ID: 36638887
[TBL] [Abstract][Full Text] [Related]
3. Recalibration of Framingham risk for a local population of Sri Lanka.
Ranasinghe SU; Ekanayake EMDS; Ranasinghe LI; Tennakoon SUB
BMC Public Health; 2024 Jan; 24(1):165. PubMed ID: 38216900
[TBL] [Abstract][Full Text] [Related]
4. Recalibration of a Framingham risk equation for a rural population in India.
Chow CK; Joshi R; Celermajer DS; Patel A; Neal BC
J Epidemiol Community Health; 2009 May; 63(5):379-85. PubMed ID: 19179368
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk prediction tools for populations in Asia.
; Barzi F; Patel A; Gu D; Sritara P; Lam TH; Rodgers A; Woodward M
J Epidemiol Community Health; 2007 Feb; 61(2):115-21. PubMed ID: 17234869
[TBL] [Abstract][Full Text] [Related]
6. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data.
Bhopal R; Fischbacher C; Vartiainen E; Unwin N; White M; Alberti G
J Public Health (Oxf); 2005 Mar; 27(1):93-100. PubMed ID: 15749725
[TBL] [Abstract][Full Text] [Related]
7. Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya.
Wekesah FM; Mutua MK; Boateng D; Grobbee DE; Asiki G; Kyobutungi CK; Klipstein-Grobusch K
Int J Cardiol Heart Vasc; 2020 Jun; 28():100521. PubMed ID: 32373711
[TBL] [Abstract][Full Text] [Related]
8. Geographic and sociodemographic variation of cardiovascular disease risk in India: A cross-sectional study of 797,540 adults.
Geldsetzer P; Manne-Goehler J; Theilmann M; Davies JI; Awasthi A; Danaei G; Gaziano TA; Vollmer S; Jaacks LM; Bärnighausen T; Atun R
PLoS Med; 2018 Jun; 15(6):e1002581. PubMed ID: 29920517
[TBL] [Abstract][Full Text] [Related]
9. Population-Based Recalibration of the Framingham Risk Score and Pooled Cohort Equations.
Sud M; Sivaswamy A; Chu A; Austin PC; Anderson TJ; Naimark DMJ; Farkouh ME; Lee DS; Roifman I; Thanassoulis G; Tu K; Udell JA; Wijeysundera HC; Ko DT
J Am Coll Cardiol; 2022 Oct; 80(14):1330-1342. PubMed ID: 36175052
[TBL] [Abstract][Full Text] [Related]
10. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study.
Boateng D; Agyemang C; Beune E; Meeks K; Smeeth L; Schulze MB; Addo J; de-Graft Aikins A; Galbete C; Bahendeka S; Danquah I; Agyei-Baffour P; Owusu-Dabo E; Mockenhaupt FP; Spranger J; Kengne AP; Grobbee DE; Klipstein-Grobusch K
Int J Cardiol; 2018 Mar; 254():310-315. PubMed ID: 29407113
[TBL] [Abstract][Full Text] [Related]
14. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations.
Gaziano TA; Pandya A; Steyn K; Levitt N; Mollentze W; Joubert G; Walsh CM; Motala AA; Kruger A; Schutte AE; Naidoo DP; Prakaschandra DR; Laubscher R
BMC Med; 2013 Jul; 11():170. PubMed ID: 23880010
[TBL] [Abstract][Full Text] [Related]
15. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Reed ML; Kurth T; Fanning KM; Buse DC
Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165
[TBL] [Abstract][Full Text] [Related]
16. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
Al-Shamsi S; Govender RD; King J
BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 30-Year Framingham Risk Score in a German Population-Based Cohort.
Rospleszcz S; Starnecker F; Linkohr B; von Scheidt M; Gieger C; Schunkert H; Peters A;
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454012
[TBL] [Abstract][Full Text] [Related]
18. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
